Physician profile
Michael T Ingram
NPI 1699773788
$6,448.93
in general payments reported to CMS, 2019-2025
17 companies · $261 in 2025
The $261 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,705 · 2020: $447 · 2021: $408 · 2022: $682 · 2023: $794 · 2024: $1,152 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,206.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,855.88 | 2019-2025 | Epic, Mitraclip |
| Edwards Lifesciences Corporation | $1,199.35 | 2019-2025 | Sapien 3 Ultra Resilia, Inspiris Resilia Aortic Valve, Hemosphere |
| Abiomed | $668.27 | 2019-2025 | Impella |
| Artivion, INC. | $344.88 | 2019-2020 | |
| Atricure, INC. | $265.94 | 2022-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Cook Medical LLC | $258.76 | 2024 | Zenith, Zilver Ptx |
| Livanova USA, INC. | $127.66 | 2019-2021 | |
| Boston Scientific Corporation | $122.40 | 2019 | |
| W. L. Gore & Associates, INC. | $120.97 | 2019 | |
| Medtronic Vascular, INC. | $120.59 | 2019-2020 | |
| Terumo Cardiovascular Systems Corporation | $96.37 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.67 | 2019-2021 | |
| Medtronic, INC. | $49.30 | 2021 | |
| Getinge USA Sales, LLC | $40.09 | 2019 | |
| Bolton Medical INC | $32.64 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $31.54 | 2019 | |
| Pfizer INC. | $25.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ingram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.